173 related articles for article (PubMed ID: 20550533)
1. The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease.
Hammer F; Edwards NC; Hughes BA; Steeds RP; Ferro CJ; Townend JN; Stewart PM
Clin Endocrinol (Oxf); 2010 Nov; 73(5):566-72. PubMed ID: 20550533
[TBL] [Abstract][Full Text] [Related]
2. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
3. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A
J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687
[TBL] [Abstract][Full Text] [Related]
4. Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition.
Dullaart RP; Ubels FL; Hoogenberg K; Smit AJ; Pratt JJ; Muntinga JH; Sluiter WJ; Wolthers BG
J Clin Endocrinol Metab; 1995 Oct; 80(10):3002-8. PubMed ID: 7559888
[TBL] [Abstract][Full Text] [Related]
5. Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone.
Espiard S; McQueen J; Sherlock M; Ragnarsson O; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Skrtic S; Wahlberg J; Stewart PM; Johannsson G
J Clin Endocrinol Metab; 2021 Mar; 106(3):814-825. PubMed ID: 33236103
[TBL] [Abstract][Full Text] [Related]
6. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
Zhai X; Chen F; Zhu C; Lu Y
J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
[TBL] [Abstract][Full Text] [Related]
7. Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
Gross E; Rothstein M; Dombek S; Juknis HI
Am J Kidney Dis; 2005 Jul; 46(1):94-101. PubMed ID: 15983962
[TBL] [Abstract][Full Text] [Related]
8. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction.
Weir RA; Tsorlalis IK; Steedman T; Dargie HJ; Fraser R; McMurray JJ; Connell JM
Eur J Heart Fail; 2011 Dec; 13(12):1305-13. PubMed ID: 21940729
[TBL] [Abstract][Full Text] [Related]
10. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
[TBL] [Abstract][Full Text] [Related]
11. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone antagonists for preventing the progression of chronic kidney disease.
Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
[TBL] [Abstract][Full Text] [Related]
13. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
14. Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study.
Boesby L; Elung-Jensen T; Klausen TW; Strandgaard S; Kamper AL
PLoS One; 2011; 6(11):e26904. PubMed ID: 22073219
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas.
Maser-Gluth C; Reincke M; Allolio B; Schulze E
Eur J Clin Invest; 2000 Dec; 30 Suppl 3():83-6. PubMed ID: 11281375
[TBL] [Abstract][Full Text] [Related]
16. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
Ferrari P; Sansonnens A; Dick B; Frey FJ
Hypertension; 2001 Dec; 38(6):1330-6. PubMed ID: 11751713
[TBL] [Abstract][Full Text] [Related]
17. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
N'Gankam V; Uehlinger D; Dick B; Frey BM; Frey FJ
Kidney Int; 2002 May; 61(5):1859-66. PubMed ID: 11967038
[TBL] [Abstract][Full Text] [Related]
18. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.
Edwards NC; Steeds RP; Stewart PM; Ferro CJ; Townend JN
J Am Coll Cardiol; 2009 Aug; 54(6):505-12. PubMed ID: 19643310
[TBL] [Abstract][Full Text] [Related]
19. Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; McInnes GT; Ford I; Connell JM; MacDonald TM
J Hypertens; 2010 Jan; 28(1):170-7. PubMed ID: 20009770
[TBL] [Abstract][Full Text] [Related]
20. Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial.
Edwards NC; Price AM; Mehta S; Hiemstra TF; Kaur A; Greasley PJ; Webb DJ; Dhaun N; MacIntyre IM; Farrah T; Melville V; Herrey AS; Slinn G; Wale R; Ives N; Wheeler DC; Wilkinson I; Steeds RP; Ferro CJ; Townend JN
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1491-1501. PubMed ID: 34462286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
